Corporate Strategy and M&A professional focused on delivering value-enhancing strategic projects and executing strategic M&A transactions in the Pharmaceutical Industry - currently, Head of M&A, Strategic Alliances for Rising Pharmaceuticals. Before this, was Chief Strategy Officer at FDC Limited. Coming from a deep Investment banking background, employers include PwC Corporate Finance, ENAM Securities, SSKI, and ANZ Investment Bank. Prior corporate strategy, M&A at Pfizer India in the early stages of my career.Experienced in all aspects of deal origination and transaction execution encompassing initial assessment, due diligence (industry, company, accounting, legal), financial modeling, structuring, assistance in the investment committee/ board of directors process, closure, and follow-on transactions.Specialties: Transactions across capital markets, private equity, M&A, restructuring, and bankruptcy across geographies -US, India, UK, South Africa, and Bangladesh include companies in healthcare, utilities, infrastructure, real estate, transportation, retail, banks, insurance, microfinance, specialty finance, sports franchises, education.Additional expertise in creating and delivering financial modeling training for Investment Banking analysts, running an independent global ports M&A training program, and delivering Finance for Non-Finance programs to C-level executives.